Abstract

BackgroundRecently, breast cancer incidence and prevalence has been increasing. Patients' health related quality of life is important considerations in the treatment of breast cancer. The EQ-5D-3L is one of most popular instruments to measure health related quality of life. This study was aimed to evaluate the validity and reliability of EQ-5D-3L in post-operative breast cancer patients from Korea.MethodsA total of 827 patients visiting the ambulatory cancer center of 1 tertiary hospital after breast cancer surgery self-administered the EQ-5D-3L and Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B). We evaluated known-group validity using differences in the EQ-5D-3L index and EQ-VAS score according to demographic and clinical data. The discriminatory ability of the EQ-5D-3L was determined by comparing the mean FACT-B subscale scores between subjects with no problems and subjects with moderate or severe problems in each EQ-5D-3L dimension. Construct validity was evaluated by Pearson correlation coefficients among the EQ-5D-3L index and FACT-B subscales, respectively. Reliability was assessed in terms of test-retest reliability using Cohen’s kappa value and intra-class correlation coefficient (ICC).ResultsThe EQ-5D-3L index and EQ-VAS score were higher in the educated, current radiotherapy and unmarried groups. The correlation of EQ-5D-3L index and subscales for the FACT-B was highest in physical well-being (r = 0.553) and lowest in social well-being (r = 0.199). For reliability, the Kappa values’ range was from 0.32 to 0.70, and ICCs of the EQ-5D-3L index and EQ-VAS scores were 0.70 and 0.48, respectively.ConclusionsThis study indicated that the EQ-5D-3L could be a valid health related quality of life instrument for postoperative breast cancer patients.

Highlights

  • Breast cancer incidence and prevalence has been increasing

  • The initial 150 recruited subjects were requested to complete an EQ-5D-3L questionnaire 1 week later via mail to assess the test-retest reliability of each patient

  • The discriminatory ability of the EQ-5D-3L was determined by comparing the mean Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B) subscale scores between subjects with no problems and subjects with moderate or severe problems in each EQ-5D-3L dimension

Read more

Summary

Introduction

Patients' health related quality of life is important considerations in the treatment of breast cancer. The EQ-5D-3L is one of most popular instruments to measure health related quality of life. Health-related quality of life (HRQoL) and traditional clinical outcomes (i.e., survival rate or tumor responses) are considered as significant outcomes of cancer care [3]. Diseasespecific instruments can be more sensitive for detecting clinically important differences or changes in specific disease groups in general, general instrument is occasionally not inferior to disease-specific instrument [9]. They do not compare HRQoL of patients with other diseases [8]. Resource allocation for health care has been a critical issue, for its effectiveness, and

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.